Content about Massachusetts

CAMBRIDGE, Mass. — An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

PatientsLikeMe said patients will be able to report daily glucose levels, as well as continue sharing and learning from HbA1C scores, treatments and dosages, in addition to symptoms and severity.

The feature will be launched in early December, PatientsLikeMe said.

CAMBRIDGE, Mass. — A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.

Genzyme, acquired earlier this year by French drug maker Sanofi, announced results of the phase-3 "CARE-MS II" trial of Lemtrada (alemtuzumab), saying the drug "significantly reduced" worsening of disability and relapse in patients with MS, compared with Rebif (interferon beta-1a), made by Pfizer and German drug maker Merck KGaA, a separate company from U.S.-based Merck.

QUINCY, Mass. — Stop & Shop announced that it is debuting a new store format in Chelmsford, Mass.

According to the company, the 72,000-sq.-ft. store will replace the former 38,500-sq.-ft. location in Chelmsford.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.

Takeda and Millennium, the Japanese drug maker's cancer-drug subsidiary, announced Tuesday that the FDA approved a supplemental new drug application for the injectable multiple myeloma drug Velcade (bortezomib) that updates its label to include additional data from a clinical study showing that the drug extended patients' survival time.

PITTSFIELD, Mass. — BJ's Wholesale Club is slated to open its newest store in Massachusetts this weekend, the company announced Tuesday.

The more than 85,000-sq.-ft. club, located in Pittsfield, joins 23 other BJ's clubs throughout the state.

The club's operating hours will befrom 9 a.m. to 9 p.m., Monday through Saturday, and 9 a.m. to 7 p.m. on Sunday.

PARIS — Sanofi has appointed David Meeker as CEO of Genzyme, the French drug maker said.

Sanofi bought the Cambridge, Mass.-based biotech manufacturer for $20.1 billion earlier this year.

"After working closely with David over the past six months, I am confident that he is the best person to lead Genzyme," Sanofi CEO Christopher Viehbacher said. "David's commitment to employees, physicians and patients has been a key success factor in the successful integration of Genzyme as part of the Sanofi Group."

CAMBRIDGE, Mass. — Hair care brand Living Proof, which is sold at such retailers as Sephora and Ulta, has launched its latest breakthrough in hair care: Restore.

"Restore really challenges the status-quo. It is a solution that addresses the causes of dryness and damage, offering immediate and long-term benefits, without oils and silicones," Living Proof co-founder and CEO Jon Flint said. "Living Proof aims to solve the toughest beauty problems. We're not satisfied with offering just a quick fix."

BURLINGTON, Mass. — Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

The study found that DPP-IV inhibitors and GLP-1 analogues would experience the biggest growth in market share among all drug classes, with a combined market share that will increase from 20% in 2010 to 47% in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

NORWELL, Mass. — Carex Health Brands on Monday introduced its new Hot & Cold Compression 2-in-1 Universal Wrap.

Featuring doctor-recommended moist heat to increase blood flow, reduce pain and relax muscles, the flexible compression wrap offers the benefit of compression with the added support of hot and cold therapy. Compression therapy supports tired or injured muscles and increases circulation in the affected area, while moist heat dilates blood vessels bringing fresh blood, oxygen and nutrients to the muscle enabling it to heal faster. 

WESTBOROUGH, Mass. — BJ's Wholesale Club officially is owned by Leonard Green & Partners and CVC Capital Partners, just a few weeks after the retailer's stockholders approved the agreement.

BJ's was required in an all-cash transaction valued at $51.25 per share, or $2.8 billion.

BJ’s common stock will be delisted from the New York Stock Exchange prior to the opening of business on Monday, Oct. 3, the companies said.

The deal was announced in late June after months of speculation. BJ’s board of directors unanimously approved the agreement.

SPRINGFIELD, Mass. — Big Y is saying "so long," to its self-service checkout lanes at its stores, according to published reports.

The New England-based retailer is slated to phase out self-serve lanes at all 61 locations.